Evidence map›Paper›PMID 41098698›Full record

ArticleFrontiers in oncology2025

Rare renal tumor: a case report of juxtaglomerular cell tumor and literature review.

Cheng Zhu, Zhong Tian, Yingfang Zhang, Tingting Yang, Zhongcong He, Shicheng Chen, Bo Yu, Neng Zhang, Ni Fu

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cheng Zhu *Department of Urology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Zhong Tian *Department of Urology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Yingfang ZhangDepartment of Nursing, The Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Tingting YangDepartment of Pathology, The Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Zhongcong HeDepartment of Urology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Shicheng ChenDepartment of Urology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Bo YuDepartment of Urology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Neng ZhangDepartment of Urology, The Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Ni FuDepartment of Urology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Juxtaglomerular Cell Tumor (JGCT) is an extremely rare neoplasm of the kidney that poses a significant clinical challenge in terms of accurate diagnosis. The key to successful treatment lies in the accurate identification of renal lesion. Excessive secretion of renin by JGCT causes activation of renin-angiotensin-aldosterone system (RAAS) secondary to uncontrollable hypertension, hypokalemia and consequently a range of clinical manifestations. While most JGCTs are benign, there have been reports of malignant cases, thus requiring close follow-up. In this case report, the subject is a middle-aged female patient who has suffered from recurrent poorly controlled blood pressure for a number of years. Following a medical examination, the patient was found to have the right renal mass, which was pathologically confirmed to be JGCT after laparoscopic partial right nephrectomy. Thereafter, the patient's blood pressure recovered steadily during the subsequent follow-up period. Furthermore, a comprehensive summary of the diagnosis, differential diagnosis, treatment and review of case reports of JGCT from the last decade is provided, encompassing malignant biological behaviors.

Indexed as

case reportdifferential diagnosishypertensionjuxtaglomerular cell tumorrare diseasereview

Identifiers

PMID41098698
PMCPMC12518060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.